← FDA DRUG APPROVALS

FDA NDA · NDA020841

LOTEMAX

Sponsor: PHARMOS

APPLICATION
NDA020841
TYPE
NDA
ORIGINAL APPROVAL
1998-03-09
LATEST ACTION
1998-03-09
ROUTE
OPHTHALMIC
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
Discontinued

Products

LOTEMAXDiscontinued
LOTEPREDNOL ETABONATE 0.5% · SUSPENSION/DROPS · OPHTHALMIC

Approval history

1998-03-09Type 6 - New Indication (no longer used) · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →